LRIG1 and renal cell carcinoma: Owing to its interesting chromosomal localisation and its potentially EGFR-inhibiting qualities, we found it of interest to examine the expression of LRIG1 in RCC and to evaluate its relationship with the expression of EGFR, in RCC and in normal kidney tissue from the same patients.